Dopamine D2 Receptor Occupancy in Patients with Schizophrenia Treated with DSP-5423P Using PET.
Phase 2
- Conditions
- Schizophrenia
- Registration Number
- JPRN-jRCT2080221869
- Lead Sponsor
- Dainippon Sumitomo Pharma Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patients who have a diagnosis of schizophrenia as defined by DSM-IV-TR
- 20 years old or more and under 64 years old or less, etc.
Exclusion Criteria
- Patients who fall under a contraindication listed in the LONASEN package insert
- Patients with Parkinson disease, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method